Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Healthcare Stocks Added to HealthInvest Partners’ Portfolio in Q1

HealthInvest Partners is a Stockholm-based fund management company founded by Carl Bennet and Anders Hallberg in 2006. The investment approach employed by the Swedish investment firm seeks to find companies with low valuations and possible catalysts to drive shareholder value. While only a few stock market participants know about this investment firm, HealthInvest Partners has performed incredibly well since inception. The firm’s HealthInvest Value Fund generated a net-of-fees return of 7% in 2015, after gaining 33% in 2014 and 35% in 2013. In fact, HealthInvest Value Fund has not suffered a down year in the past seven years or so, with its return reaching 22% per annum. Considering the exceptional performance of the Stockholm-based investment firm relative to the overall hedge fund industry in recent years, it seems like a great idea to have a look at the fund’s equity portfolio. HealthInvest Partners recently submitted the 13F filing for the first quarter of this year, so this article will discuss five new additions to the fund’s portfolio during the quarter.

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see more details here).

OraSure Technologies Inc. (NASDAQ:OSUR)

– Number of shares held by HealthInvest Partners as of March 31: 405,771

– Value of HealthInvest’s holding as of March 31: $2.93 Million

HealthInvest Partners acquired a new stake of 405,771 shares in OraSure Technologies Inc. (NASDAQ:OSUR) during the March quarter, which was valued at $2.93 million at quarter-end. The company develops and markets products and specimen collection devices using proprietary technologies. OraSure Technologies completed the design of a rapid Ebola antigen test using its OraQuick platform in early 2015. The test has already received an Emergence Use Authorization (EUA) from the FDA for use by laboratories and facilities that are adequately equipped and trained to test Ebola infection. The company recognized $2.3 million in revenues last year from the sale of this product to the Centers for Disease Control and Prevention (CDC) for investigational use and field testing in Africa. OraSure Technologies reported consolidated net revenues of $119.7 million for 2015, which increased from $106.5 million in 2014. The company’s management anticipates consolidated net revenues in the range of $28.5 million-to-$29.0 million for the first quarter of the current year. Shares of OraSure have gained 14% since the beginning of 2016 and are up 8% in the past 12 months. Ken Fisher’s Fisher Asset Management reported owning 824,592 shares of OraSure Technologies Inc. (NASDAQ:OSUR) through the latest round of 13Fs.

Follow Orasure Technologies Inc (NASDAQ:OSUR)
Trade (NASDAQ:OSUR) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.